The US IPO market in the 1Q16 hit its lowest levels since the depths of the financial crisis in 2008/2009. Not a single deal priced outside of the health care sector, where eight deals managed to raise $0.7 billion thanks to substantial buying by their existing...read more
Of the three scheduled healthcare offerings this past week, only two priced. This marks a total of seven IPOs year to date, all from healthcare companies, which have been predominantly development stage biotechs supported by existing backers. While the broader...read more
Senseonics Holdings, which is developing a long-lasting implantable glucose monitor for diabetics, raised $45 million by offering 15.8 million shares at $2.85. Senseonics Holdings plans to list on the NYSE MKT under the symbol SENS. Leerink Partners and...read more
Senseonics Holdings, which is developing a long-lasting implantable glucose monitor for diabetics, lowered the proposed deal size for its upcoming IPO on Thursday. The Germantown, MD-based company now plans to raise $45 million by offering 15.8 million...read more
Renaissance Capital's 1Q16 US IPO Market Review
The US IPO market in the 1Q16 hit its lowest levels since the depths of the financial crisis in 2008/2009. Not a single deal priced outside of the health care sector, where eight deals managed to raise $0.7 billion thanks to substantial buying by their existing...read more
US IPO Weekly Recap: Two healthcare companies price amid an improving market backdrop
Of the three scheduled healthcare offerings this past week, only two priced. This marks a total of seven IPOs year to date, all from healthcare companies, which have been predominantly development stage biotechs supported by existing backers. While the broader...read more
Senseonics prices IPO at $2.85
Senseonics Holdings, which is developing a long-lasting implantable glucose monitor for diabetics, raised $45 million by offering 15.8 million shares at $2.85. Senseonics Holdings plans to list on the NYSE MKT under the symbol SENS. Leerink Partners and...read more
Pre-revenue glucose monitor maker Senseonics decreases proposed IPO deal size
Senseonics Holdings, which is developing a long-lasting implantable glucose monitor for diabetics, lowered the proposed deal size for its upcoming IPO on Thursday. The Germantown, MD-based company now plans to raise $45 million by offering 15.8 million...read more